Assembly Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
ASMB chart
What traders are saying about $ASMB
Latest postsAssembly Biosciences, Inc. news
- Healthcare stocks with strong revenue growth and attractive valuations
TradingView ·
- Technical Reactions to ASMB Trends in Macro Strategies
Stock Traders Daily ·
- Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases
Yahoo Finance ·
- Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
Yahoo Finance ·
- Best Momentum Stocks to Buy for September 17th
Yahoo Finance ·
- New Strong Buy Stocks for September 17th
Yahoo Finance ·
- Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
Yahoo Finance ·
- Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
Yahoo Finance ·
- Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Yahoo Finance ·
- Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services
Yahoo Finance ·
- Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
Yahoo Finance ·
- Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
Yahoo Finance ·
Assembly Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $72.3M | $28.5M | – | – |
| Net income | -$6.1M | -$40.2M | -$61.2M | -$93.1M |
| Diluted EPS | $-0.55 | $-6.69 | $-13.38 | $-23.08 |
| Total assets (year end) | $257.6M | $119.2M | $136.8M | $101.8M |
| Cash and equivalents (year end) | $58.5M | $38.3M | $19.8M | $52.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Assembly Biosciences, Inc.
- Ticker
- ASMB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1426800
- Former names
- VENTRUS BIOSCIENCES INC
Frequently asked questions
What exchange is Assembly Biosciences, Inc. listed on?
Assembly Biosciences, Inc. trades on the Nasdaq under the ticker symbol ASMB.
What industry is Assembly Biosciences, Inc. in?
Assembly Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Assembly Biosciences, Inc. headquartered?
Assembly Biosciences, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Assembly Biosciences, Inc.'s fiscal year end?
Assembly Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Assembly Biosciences, Inc. report?
Assembly Biosciences, Inc. reported $72.3M in revenue for calendar year 2025, according to its SEC filings.